Results 141 to 150 of about 3,929 (267)

Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo, Dinesh Khanna, Corrado Campochiaro, Vincent Cottin, Fabrizio Luppi, Marco Matucci‐Cerinic, Gianluca Moroncini, Yannick Allanore   +7 more
wiley   +1 more source

Utility of Harmonisation for Fixel-Based Metrics in Travelling Subjects and Alzheimer's Disease Data. [PDF]

Hum Brain Mapp
Zou R, Kamagata K, Mito R, Takabayashi K, Andica C, Uchida W, Guo S, Kitagawa T, Fujita S, Uematsu A, Maikusa N, Koike S, Aoki S, Alzheimer's Disease Neuroimaging Initiative.   +13 more
europepmc   +1 more source

The impact of harmonisation by the International Federation of Accountants: an empirical study of the informational value of Tunisian auditors’ reports on annual financial statements

, 2008
Purpose – This paper examines the impact of the new, revised International Standard on Auditing (Revised ISA700) in terms of the wording characteristics of Tunisian auditors’ reports. Design/methodology/approach – measurement of the compliance of auditors’ reports issued by Tunisian auditors with the new revised International Standard on
Pucheta-Martínez, María Consuelo, Fakhfakh, Mondhef, Fakhfakh, Hamadi   +2 more
openaire   +1 more source

Operationalizing BioSSbD: A safe‐and‐sustainable‐by‐design framework for biorefineries

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Biorefineries are central to the transition toward a circular bioeconomy; however, their increasing scale and technological heterogeneity, and the integration of biological, chemical, and thermochemical processes introduce complex challenges related to safety, sustainability, and operational reliability. Existing Safe‐and‐Sustainable‐by‐Design
Fernando Ramonet
wiley   +1 more source

Searching for the accounting features of capitalism: an illustration with the economic transition process in China [PDF]

In this paper, the authors show that capitalism and double-entry bookkeeping are not indissociably interconnected as Sombart argued in his book in 1916. Indeed, the double-entry bookkeeping accounting system was also adopted by anti-capitalist countries ...
Chiapello, Eve, Ding, Yuan
core  

Measuring cancer equity globally: harmonising international rural-urban classifications for exploring cancer outcomes. [PDF]

Lancet Reg Health West Pac
Wright C, Riva S, Crichton M, Rodi H, Jongebloed H, Leigh L, Johnston EA, Bergin RJ, Chapman A, Alston L, Crawford-Williams F, Hart NH, Rhee J, Gao L, Gunn K, Gasper H, Ugalde A, Marshall S.   +17 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Measurement of de facto armonisation: The case of participating investments in Italy

, 2007
With the issuing of Commission Regulation n. 1606/2002, which requires all EU listed companies to adopt International Financial Reporting Standards (IAS/IFRS) from 2005 onwards, the accounting harmonisation process in Europe has come to a relevant stage.
CATUOGNO, SIMONA
core  

Cerebrospinal Fluid and Plasma Concentrations of Atogepant in Humans. [PDF]

Clin Transl Sci
Boinpally RR, Trugman JM.
europepmc   +1 more source

A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials

British Journal of Clinical Pharmacology, EarlyView.
Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on predefined thresholds to determine clinically meaningful change.
Anna Margarete Maria Thurner, Daniela Krepper, Micha Johannes Pilz, Lisa Marie Storz, Maike Thumfart, Johannes Maria Giesinger   +5 more
wiley   +1 more source